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Abstract Major depression commonly co-occurs with
symptoms of insomnia. However, the underlying psycho-
biological mechanisms which can explain this relationship
are still not well understood. Hyperarousal and negative
emotionality have been proposed to be possible mediating
factors. Several studies have suggested that insomnia could
be a predictor of depression. A recent meta-analysis
conducted by our group showed that people with insomnia
have a two-fold risk to develop depression, compared to
people with no sleep difficulties. Thus, early diagnosis and
treatment of insomnia could, at least partially, prevent the
development of future depression, by identifying people at
risk for depression and deliver personalized intervention
protocols to improve individual outcome. Modifications of
existing treatment modules are needed, as adding sleep
protocols to the treatment of depression and affective
regulation protocols to the treatment of insomnia, enhance
the accessibility for the treatment of insomnia, and develop
sleep education protocols in early periods of life.
Keywords Depression . Insomnia . Clinical predictor .
Cognitive behaviour therapy for insomnia . First level
interventions . Prevention
Depression
Major depression is a heterogeneous disorder with a
variable course which is associated with high levels of
disability, impairment in quality of life, and increased
mortality rates. It adversely affects physical health, cogni-
tive performance, and social relationships.
According to the American Psychiatric Association’s
Diagnostic and Statistical Manual of Mental Disorders
Fourth Edition [1], the diagnosis of major depression
requires the presence (for a period of 2 weeks) of at least
five out of a list of nine symptoms that include, for
example, sadness, loss of interest in usual activities,
lowered appetite, fatigue, insomnia symptoms, and suicidal
ideas. Depression is the leading cause of disability in both
women and men in United States and worldwide and one of
the ten leading disorders for global disease burden [2]. In
Europe it has been estimated that around 13% of the
population have a major depressive episode at some time of
their lives [3]. It comprises 6% of the total disease burden
and almost 1/3 of all neuropsychiatric diseases and the costs
of depression correspond to 1% of the total economy of
Europe [4]. Beside the high prevalence, depression has also
a recurrent aspect, i.e. a person who suffered from
depression once is vulnerable to relapses. Despite of the
high impact of depression in the general population,
consensus reports underline that individuals with depres-
sion are being underdiagnosed and undertreated [5]. The
increase in the prescription of antidepressants registered
over the past 20 years is mostly dependent on increased
long-term prescribing, but not on early recognition of
depression [6]. The clear necessity of deepening the
knowledge about the treatment of depression in order to
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reduce its impact on modern society requires a further effort
in the recognition of clinical early predictors of depression
and the development of alternative treatments.
Depression and insomnia
Major depression commonly co-occurs with symptoms of
insomnia [7, 8]. The International Classification of Sleep
Disorders (2nd edition [9]) defines insomnia as a difficulty in
initiating/maintaining sleep or non-restorative sleep accom-
panied by decreased daytime functioning, such as fatigue/
malaise, daytime sleepiness, mood disturbance/irritability,
motivation/energy/initiative reduction, and attention/concen-
tration/memory impairment, persisting for a period of at least
4 weeks. The relationship between depression and insomnia
has been observed for a long time. Already at the beginning
of the 20th century, Kraepelin [10] described the close link
between the two conditions. Nevertheless, the conceptuali-
zation of this relationship has radically changed during the
last decade. Insomnia has been traditionally viewed in the
field of psychiatry as a symptom of psychopathology,
especially depression (overview see [11, 12]). More recently,
insomnia has been re-considered as a primary disorder if it is
present without the co-existence of other clinically relevant
psychiatric or medical diseases, and as a secondary disorder
if otherwise. Considering the link to depression, however,
chronic insomnia can also exist years before the first onset of
a depressive episode. Consequently, it has been suggested
that “comorbid” insomnia may be a more appropriate term
than “secondary” insomnia [13–15]. Insomnia and depres-
sion are conceptualized now as two independent diagnostic
entities with different clinical courses and characteristics
which share some psychobiological characteristics, as for
example hyperarousal [12]. The next edition of DSM, DSM-
V, will probably abandon the primary/secondary concept and
instead introduce “insomnia disorder” as the main diagnostic
category for insomnia, allowing specification whether or not
it is co-morbid with another mental or medical disorder [16].
Causal relationship between depression and insomnia:
possible psychobiological mechanisms
The psychobiological mechanisms that underline the relation-
ship between depression and insomnia are still not well
understood. Neurobiological and sleep EEG studies indicate
that high levels of arousal could explain the close link between
the two conditions and represent a possible mediating factor.
Another possible mechanism involved is altered emotionality.
Koffel and Watson [17] evaluated the relationship between
nighttime and daytime symptoms of insomnia and depres-
sion. Nighttime symptoms were defined as poor sleep quality,
long sleep latency, and minutes awake at night; daytime
symptomswere conceptualized as fatigue and sleepiness. This
relationship was tested in three different samples: 349 college
students, 213 older adults, and 266 psychiatric outpatients.
Both nighttime and daytime symptoms of insomnia were
found to be significantly related to depression. Moreover,
daytime symptoms were associated with a higher negative
emotionality and a lower positive emotionality in all three
samples. Based on these results, it can be assumed that
heightened negative emotionality and diminished positive
emotionality explain the psychological mechanism which
mediates the relationship between insomnia and depression
[18]. That is, insomnia may lead to depression by altering
emotional responses. Consistently, altered emotional
responses to visual stimuli have been reported in people
with insomnia as compared to good sleepers [19]. It may be
speculated that initially primary insomnia is a condition
strictly connected to hyperarousal (e.g. [20]), which if it gets
chronic impairs also the emotional system leading to the
increased risk to develop depression.
Insomnia as a clinical early predictor of depression:
results from a meta-analytic study
The link between depression and insomnia is very close; up
to 80% patients with depression have sleep complaints
consistent with insomnia [8]. The high percentage suggests
that the two conditions are not just randomly associated.
Several authors have proposed that insomnia could be a
predictor of depression instead of being just a symptom of
affective disorders.
Ford and Kamerow [21] were the first to note that a
causal relationship between insomnia and depression exists
based on data from a longitudinal epidemiological study.
Since then more than 40 studies have been published
evaluating the predictor question (overview see [18, 22]). A
recent study from our group aimed at evaluating the causal
link between insomnia and depression by performing a
meta-analysis of longitudinal epidemiological studies [23].
Considering all relevant longitudinal studies published from
1980 to 2010, 46 studies were identified which evaluated
simultaneously insomnia complains and depressed psycho-
pathology. Within these, 25 studies were excluded as they
did not satisfy the following criteria: 1) insomnia predicting
follow-up depression and not the other way round; 2)
definition of sleep complaints consistent with the DSM-IV
definition of insomnia; 3) depression assessed basing on the
DSM-IV definition or through standardized questionnaires;
4) participants with significant depression at baseline
excluded from the study; 5) follow-up conducted at least
after 12-months from the baseline; 6) effect size reported
and/or computable.
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The 21 studies selected for meta-analytic computations
had a mean sample size at follow-up of 3200 participants
with a mean age of 46 years (sd=22.4). The mean
percentage of women in the studies was of 55% (sd=4.5),
excluding one study in which all participants were males
[24]. On average, the follow-up assessment was conducted
after 71 months (sd=96.0). Descriptive characteristics of
the included studies are reported in Table 1.
Incidence of depression at follow-up in people with
insomniac symptoms was in percentage 13.1%, while it was
4.0% in people without sleep difficulties. Considering that
an incidence rate of 9.9% has been reported for depression
in the general population [44], it is interesting to notice that:
a) the incidence is high in patients with insomnia and b) the
incidence is extremely reduced in a group without any
experience of sleep difficulties.
The logarithms of the odds ratios and their confidence
intervals (CI) were used for meta-analytic calculations.
Considering all the 21 studies selected together, the
heterogeneity index was statistically significant (Q-value =
124.7; df(Q) = 20; p<0.001; and I2=84.0). By performing
sensitivity analysis, it was found that the majority of
heterogeneity between studies was explained by those
studies which reported standardized residuals of >+3 or
<−3 [21, 26, 32, 37]. Excluding these outliers from the
analysis, the heterogeneity test was not longer significant
(Q-value = 20.1; df(Q) = 16; p=0.2; and I2=20.3). The
summarized odd ratios determined by applying the “fixed-
effects meta-analytic model” was of 2.1 (CI: 1.9–2.4; see
Fig. 1).
Classifying the studies according to age, we consid-
ered three groups: working-age group, elderly group
(>60), and a children and adolescent group. The same
meta-analytic calculations were applied to each one of
these three age-groups. Studies with mixed-age partic-
ipants (i.e. studies recruiting participants aged 18 years
or older) were not considered for age-groups calcula-
tions. The elderly group was heterogeneous (Q-value =
8.8; df(Q) = 5; p=0.1; and I2=43.1), however this
heterogeneity was explained by studies which considered
clinical samples and not the general population as the
other studies [26, 34, 35]. Once we excluded data from
these studies, we found non-heterogeneity between studies
in all three age-groups. The summarizing odds ratios for
these three age-groups were respectively: 2.1 (CI: 1.7–2.6)
for the working-age group; 1.9 (CI: 1.6–2.3) for the
elderly group; and 2.0 (CI: 1.5–2.7) for the children and
adolescents group.
Table 1 Study descriptive characteristics
Authors and Publ Year N (bsl) N (fu) m_age age_group fu (months) OR (95%CI)
Ford and Kamerow [21], 1989 10.534 7.954 45.79 Mixed (>18 years) 12 39.8 [19.8–80.0]
Vollrath et al. [25], 1989 591 457 21.0 Working 84 2.2 [1.2–4.0]
Brabbins et al. [26], 1993 1.070 701 69.8 Elderly 36 1.4 [1.1–1.8]
Breslau et al. [27], 1996 1.007 979 26.1 Working 42 2.1 [1.1–4.0]
Chang et al. [24], 1997 1.053 941 26.0 Working 408 1.9 [1.2–3.2]
Weissman et al. [28], 1997 18.571 7.113 48.2 Mixed (>18 years) 12 5.4 [2.6–11.3]
Foley et al. [29], 1999 9.282 6.899 80.1 Elderly 36 1.7 [1.3–2.2]
Johnson et al. [30], 2000 823 717 6.0 Child and ado 60 1.5 [0.4–6.5]
Mallon et al. [31], 2000 1.870 1.244 55.0 Working 144 2.8 [1.6–4.9]
Roberts et al. [32], 2000 2.730 2.370 64.9 Mixed (>18 years) 12 4.9 [3.1–7.6]
Roberts et al. [33], 2002 4.175 3.136 15.0 Child and ado 12 1.9 [1.3–1.9]
Hein et al. [34], 2003 775 664 60.0 Elderly 60 2.4 [1.3–4.5]
Perlis et al. [35], 2006 247 147 72.0 Elderly 12 6.9 [1.3–36.1]
Morphy et al. [36], 2007 2.363 1.589 50.0 Mixed (>18 years) 12 2.7 [1.4–5.4]
Neckelmann et al. [37], 2007 74.977 25.130 54.1 Mixed (>18 years) 132 1.1 [0.8–1.6]
Buysse et al. [38], 2008 591 278 19.5 Working 240 1.6 [1.1–2.1]
Cho et al. [39], 2008 351 329 69.0 Elderly 24 3.1 [1.1–8.8]
Jansson-Fröjmark and Lindblom [40], 2008 1.812 1.489 42.0 Working 12 3.5 [2.1–5.8]
Roane and Taylor [41], 2008 4.494 3.582 16.0 Child and ado 78 2.2 [1.3–3.6]
Kim et al. [42], 2009 1.204 909 72.2 Elderly 24 2.1 [1.5–3.0]
Szklo-Coxe et al. [43], 2010 1.533 555 53.6 Working 44 2.5 [0.8–7.5]
Publ Year publication year; bsl baseline; fu follow-up; m_age mean age; OR odds ratios; CI confidence interval; mixed mixed-age group; working
working-age group; elderly elderly group; child and ado children and adolescents
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Insomnia as a clinical early predictor of depression:
what we still need to know
Results from this meta-analytic study show that people with
insomnia have a two-fold risk to develop depression,
compared to people with no insomniac sleep difficulties.
In spite of the high variability in study populations, study
designs, and measures, the pooled estimates were high and
remained high also after exclusion of the outliers. The 21
studies included in the meta-analysis had large sample sizes
and considered a large amount of time between baseline
and follow-up which allow to consider long-term relation-
ships between depression and insomnia.
The main limitation of the meta-analysis is that intervening
variables were not taken into account in many of the studies
considered, for example anxiety disorders, drug or alcohol
abuse or socio-economic situation.Moreover, the definition of
insomnia given in the DSM-IV includes three criteria: a sleep
difficulty criterion (difficulty in initiating/maintaining sleep or
non-restorative sleep); a duration criterion (a period of at least
4 weeks); and a daytime impairment criterion (decreased
daytime functioning, such as fatigue/malaise, daytime sleep-
iness, mood disturbance/irritability, motivation/energy/initia-
tive reduction, and attention/concentration/memory
impairment). However, the studies included in the meta-
analysis often failed to consider the duration and the daytime
impairment criteria. More specifically, eight of the 21 studies
based their diagnosis only on the presence of problems in
initiating and maintaining sleep, thus considering only
insomnia symptoms, but not insomnia as a disorder. It could
be possible that insomnia as a disorder has an even higher
impact on the development/incidence of depression than sleep
difficulties alone. In addition, studies on children and/or
adolescents are only few up to now: in our meta-analysis only
three studies evaluated these populations. As insomnia is a
clinical predictor of depression, studying the clinical link in
younger samples could help in developing early-detection or
prevention programs which could reduce the risk for onset of
depression in adults.
Clinical implications: how treating sleeping difficulties
could prevent the onset of depression
The close link between depression and insomnia, and the
causal role that symptoms of insomnia have in the
development of a depressive disorder necessitate not only
further research in order to understand the underlying
psychobiological mechanisms, but also argue for the
development of innovative clinical updates. Some recent
studies showed that adding cognitive-behaviour therapy for
insomnia (CBT-I) is efficacious in patients with both
symptoms of insomnia and depression and guarantees a
better treatment outcome in this population than standard
antidepressive treatment alone [45, 46]. The strategies
included in the CBT-I are summarized in Table 2.
Fig. 1 Odds ratios relative to
each single study and summa-
rizing odds ratio after exclusion
of the outliers
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Applying protocols directed to reduce sleep difficulties
and related cognitive and emotional aspects to the routine
of psychological therapy of depression seems to lead to
better outcomes and to diminish the risk for recurrent
depression. On the other hand, adding protocols directed to
ameliorate affective regulation in people with insomnia
could prevent the risk for developing depression. Consis-
tently, some preliminary research has been conducted using
the Pennebaker writing intervention to treat people with
insomnia (e.g. [47, 48]). This intervention consists of the
instruction to write down thoughts, worries and emotions. It
is supposed that writing about emotional experiences is a
method to facilitate emotional processes. Harvey and Farrel
[48] found in 44 poor sleepers that those who underwent a
3-nights Pennebaker writing intervention reported shorter
sleep-onset latencies compared to a no-writing group.
Mooney, Espie and Broomfield [47] found that a Penne-
baker writing group reported significantly reduced pre-sleep
arousal compared to a control group. However, they did not
find an effect of the intervention on sleep-onset latencies.
Further research in this area is needed to determine the
clinical relevance of this type of intervention.
With respect to possible prevention programs, based on the
results presented above, it seems reasonable that treating sleep
difficulties at an early stage can prevent affective sequelae.
Evidence-based treatments for insomnia include hypnotic
drugs, benzodiazepine (BZ) and benzodiazepine receptor
agonists (BZRA), and cognitive behavioural treatment for
insomnia (CBT-I) (overview see [49]). However, with respect
to hypnotic drugs, guidelines suggest to restrict prescriptions
to limited periods of times, i.e. 3 to 4 weeks due to the risks
inherent in these drugs, mainly tolerance and dependence.
On the other hand, CBT-I has been found to be efficacious
both at short- and long-term, but is available only to a tiny
minority of afflicted individuals, as it is still mainly limited
to academic environments and often used only in research
contexts.
As emphasized before, there is a necessity to systematically
address insomnia and to spread the possibility to access to
psychological treatment of insomnia in the general population.
One approach suggested consists in the “stepped care model”
(e.g. [50]). This model offers a generic approach to care
management by delivering low intensity treatments to a wide
number of individuals. In case of treatment failure, individuals
can step forward to next levels that are characterized by more
specialized programs and deliverers. The first level would
work as prevention program for individuals at risk, while the
superior levels would correspond to CBT-I delivered by a
psychologist.
At the first level, one possible method is to deliver CBT-I in
primary care through structured protocols delivered by
unspecialized professionals. Espie et al. [50] have found that
trained and supervised nurses can successfully deliver CBT-I
in primary care routine of general medicine practice. CBT-I
was organized in a structured protocol divided in five
sessions comprising: (a) sleep information; (b) sleep hygiene
and relaxation; (c) sleep scheduling; (d) cognitive
approaches; (e) developing a strong and natural sleep pattern.
Another possible first level alternative to spread the
CBT-I protocols in primary care and reach a large number
of individuals is the use of the internet. Internet-based
treatment has the potential to reach a large number of




Behavioural strategy. A set of instructions directed to associate the stimulus “bed” with the behaviour “sleep” and to
reinforce a regular sleep–wake schedule: 1) go to bed only when tired; 2) use the bed to sleep only (no TV; no food;
etc.); 3) plan pre-bed routines to do every night before going to bed; 4) get out of bed when unable to sleep; 5) arise at
the same time every morning; 6) no napping
Sleep restriction Behavioural strategy. A method which aims at making the patient staying in bed only for the time she or he sleeps. It
consists in reducing the time spent in bed to the mean time generally slept by the patient. The amount of time allowed to
sleep planed with the therapist should be respected also during weekends
Sleep hygiene
education
Behavioural and educational strategy. General health instructions about factors that might influence sleep (e.g. sport,
light, temperature; etc.)
Relaxation Behavioural and cognitive strategy. A set of methods aiming at reducing somatic or cognitive hyperarousal (e.g.
progressive muscle relaxation; autogenic training; imagery training; meditation)
Cognitive
reconstructing
Cognitive strategy. A strategy directed to reduce the impact of dysfunctional beliefs and attitudes about sleep
Cognitive control Cognitive strategy. The patient is instructed to sit comfortably in an armchair and write down a list of worries and a list of
what to do the next day. The rationale of this strategy is to prevent emotionally loaded intrusive thoughts during the
sleep-onset period, as all worries have been “already” processed before going to bed
Paradoxical
intention
Cognitive strategy. Strategy aimed at reducing the anticipatory anxiety at the time to fall asleep. Patients are instructed to
stay quietly in bed with the eyes closed and to try to keep awake as long as they can. This takes away the responsibility
to try to fall asleep, which in turn lead to fall asleep quicker
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people [51]. Studies which applied cognitive-behaviour
therapy to internet protocols for treating psychiatric
disorders showed that these are effective in reducing
psychological symptoms (e.g. [52]). Only three studies
investigated the efficacy of CBT-I delivered through
internet [51, 53, 54]. These studies indicate a significant
improvement in the treatment groups in total sleep time,
sleep onset latency, nocturnal awakenings, time awake at
night, sleep efficiency, sleep quality and insomnia severity.
Moreover, effects on cognitive variables, for example on
dysfunctional beliefs about sleep and pre-sleep mental
activity, and on daytime consequences were found. All the
three studies available up to date [51, 53, 54] found that
online CBT-I is efficacious. An internet-based CBT-I
program may be an effective tool to reach people that are
not willing to go to a psychotherapist.
As insomnia is a clinical predictor of depression, inter-
ventions in early periods of life could lead to significant
benefits for the individual and improve public health out-
comes. However, studies on children and adolescents are still
too few and the issue needs further investigation. Chronic
insomnia affects up to 25% of children [55]. However, only
few studies investigated treatment efficacy in this population.
Improving preventive parents’ education for children in the
earliest years of life and developing school programs for
children could have a huge impact on insomnia prevalence
and incidence. In fact, according to the transdiagnostic model
of insomnia (e.g. [56]), insomnia is not only a clinical
predictor for depression, but for psychopathology in general.
It could be possible that the treatment of insomnia is a
generally effective preventive strategy for mental health.
This effect could be even stronger in children and adoles-
cents because the future development of psychiatric disorders
in adult age might be prevented.
Conclusions and outlook
Compared to people with no sleep difficulties, people with
insomnia have a two-fold risk to develop depression. Insomnia
and depression are nowadays conceptualized as two indepen-
dent diagnostic entities with different clinical courses and
characteristics which, however, share some psychobiological
aspects, as for example hyperarousal. One possible mechanism
involved in the etiology of both insomnia and depression is
altered emotionality. It could be possible that insomnia, being a
condition strictly connected to hyperarousal, is associated with
an alteration in the emotional system, which, in turn, leads to the
increased risk for depression. This theoretical assumption has
important clinical implications. Modifications of existing
clinical treatment modules are needed in order to add sleep
protocols to the treatment of depression and protocols for
affective regulation to the treatment of insomnia. Moreover,
there is a need to enhance the accessibility for the treatment of
insomnia in the general population, either through the “stepped
care” approach or through internet programs. Finally, sleep
education protocols in early periods of life could lead to
significant benefits for the individual and improve public health
outcomes.
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